Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2004

Isamu Yoshida, Takaji Fujimura, Yoshihisa Itoh, Mineji Tachibana, Mitsuo Kaku, Keiji Kanemitsu, Choichiro Takahashi, Joji Shiotani, Yuka Ono, Hisashi Baba, Shuji Matsuo, Seishi Asari, Kimiko Matsuoka, Nobuchika Kusano, Motoko Nose, Tetsunori Saikawa, Kazufumi Hiramatsu, Shigeru Kohno, Yoichi Hirakata, Nobuhisa YamaneIsamu Nakasone, Yoshinori Yamano

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We determined MICs of antibacterial agents against 1,248 clinical strains of aerobic Gram-negative bacteria (19 genus or species) isolated at 16 Japanese facilities in 2004. MICs were determined using mostly broth microdilution method and antibacterial activity was assessed. Antibacterial susceptibility of Enterobacteriaceae to most β-lactams was comparable to that described in our previous report on isolates in 2002. Strains producing extended-spectrum β-lactamases(ESBL) accounted for 2.5% of Escherichia coli, 0% of Klebsiella spp., and 9.2% of Proteus spp. Notably, 16.7% of Proteus mirabilis was found to produce ESBL. Most antibacterial agents showed good activity against Moraxella catarrhalis. Among Haemophilus influenzae, 9.3% produced β-lactamase and 57.7% were β-lactamase-negative ampicillin-resistant strains when classified by penicillin-binding protein 3 mutation. Although few antibacterial agents against Pseudomonas aeruginosa have potent activity, only three agents-tobramycin, doripenem, and amikacin-showed an MIC90 of ≤8 μg/mL. Of all P. aeruginosa strains, 8.9% were resistant to seven or more agents of ten antipseudomonal agents, a decrease compared to results reported in 2002. Against other glucose-non-fermentative Gram-negative bacteria, the activity of most antibacterial agents was similar to that in 2002.

Original languageEnglish
Pages (from-to)562-579
Number of pages18
JournalJapanese Journal of Chemotherapy
Volume56
Issue number5
Publication statusPublished - Sep 2008

Fingerprint

Gram-Negative Aerobic Bacteria
Anti-Bacterial Agents
doripenem
Pseudomonas aeruginosa
Penicillin-Binding Proteins
Moraxella (Branhamella) catarrhalis
Lactams
Proteus mirabilis
Proteus
Tobramycin
Klebsiella
Amikacin
Haemophilus influenzae
Enterobacteriaceae
Ampicillin
Gram-Negative Bacteria
Escherichia coli
Glucose
Mutation

Keywords

  • Clinical isolate
  • Drug susceptibility
  • Gram-negative bacteria
  • Multidrug-resistant pseudomonas aeruginosa
  • Surveillance

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Yoshida, I., Fujimura, T., Itoh, Y., Tachibana, M., Kaku, M., Kanemitsu, K., ... Yamano, Y. (2008). Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2004. Japanese Journal of Chemotherapy, 56(5), 562-579.

Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2004. / Yoshida, Isamu; Fujimura, Takaji; Itoh, Yoshihisa; Tachibana, Mineji; Kaku, Mitsuo; Kanemitsu, Keiji; Takahashi, Choichiro; Shiotani, Joji; Ono, Yuka; Baba, Hisashi; Matsuo, Shuji; Asari, Seishi; Matsuoka, Kimiko; Kusano, Nobuchika; Nose, Motoko; Saikawa, Tetsunori; Hiramatsu, Kazufumi; Kohno, Shigeru; Hirakata, Yoichi; Yamane, Nobuhisa; Nakasone, Isamu; Yamano, Yoshinori.

In: Japanese Journal of Chemotherapy, Vol. 56, No. 5, 09.2008, p. 562-579.

Research output: Contribution to journalArticle

Yoshida, I, Fujimura, T, Itoh, Y, Tachibana, M, Kaku, M, Kanemitsu, K, Takahashi, C, Shiotani, J, Ono, Y, Baba, H, Matsuo, S, Asari, S, Matsuoka, K, Kusano, N, Nose, M, Saikawa, T, Hiramatsu, K, Kohno, S, Hirakata, Y, Yamane, N, Nakasone, I & Yamano, Y 2008, 'Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2004', Japanese Journal of Chemotherapy, vol. 56, no. 5, pp. 562-579.
Yoshida I, Fujimura T, Itoh Y, Tachibana M, Kaku M, Kanemitsu K et al. Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2004. Japanese Journal of Chemotherapy. 2008 Sep;56(5):562-579.
Yoshida, Isamu ; Fujimura, Takaji ; Itoh, Yoshihisa ; Tachibana, Mineji ; Kaku, Mitsuo ; Kanemitsu, Keiji ; Takahashi, Choichiro ; Shiotani, Joji ; Ono, Yuka ; Baba, Hisashi ; Matsuo, Shuji ; Asari, Seishi ; Matsuoka, Kimiko ; Kusano, Nobuchika ; Nose, Motoko ; Saikawa, Tetsunori ; Hiramatsu, Kazufumi ; Kohno, Shigeru ; Hirakata, Yoichi ; Yamane, Nobuhisa ; Nakasone, Isamu ; Yamano, Yoshinori. / Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2004. In: Japanese Journal of Chemotherapy. 2008 ; Vol. 56, No. 5. pp. 562-579.
@article{351ab9a958d2469a8cd26cf1b71f7cc1,
title = "Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2004",
abstract = "We determined MICs of antibacterial agents against 1,248 clinical strains of aerobic Gram-negative bacteria (19 genus or species) isolated at 16 Japanese facilities in 2004. MICs were determined using mostly broth microdilution method and antibacterial activity was assessed. Antibacterial susceptibility of Enterobacteriaceae to most β-lactams was comparable to that described in our previous report on isolates in 2002. Strains producing extended-spectrum β-lactamases(ESBL) accounted for 2.5{\%} of Escherichia coli, 0{\%} of Klebsiella spp., and 9.2{\%} of Proteus spp. Notably, 16.7{\%} of Proteus mirabilis was found to produce ESBL. Most antibacterial agents showed good activity against Moraxella catarrhalis. Among Haemophilus influenzae, 9.3{\%} produced β-lactamase and 57.7{\%} were β-lactamase-negative ampicillin-resistant strains when classified by penicillin-binding protein 3 mutation. Although few antibacterial agents against Pseudomonas aeruginosa have potent activity, only three agents-tobramycin, doripenem, and amikacin-showed an MIC90 of ≤8 μg/mL. Of all P. aeruginosa strains, 8.9{\%} were resistant to seven or more agents of ten antipseudomonal agents, a decrease compared to results reported in 2002. Against other glucose-non-fermentative Gram-negative bacteria, the activity of most antibacterial agents was similar to that in 2002.",
keywords = "Clinical isolate, Drug susceptibility, Gram-negative bacteria, Multidrug-resistant pseudomonas aeruginosa, Surveillance",
author = "Isamu Yoshida and Takaji Fujimura and Yoshihisa Itoh and Mineji Tachibana and Mitsuo Kaku and Keiji Kanemitsu and Choichiro Takahashi and Joji Shiotani and Yuka Ono and Hisashi Baba and Shuji Matsuo and Seishi Asari and Kimiko Matsuoka and Nobuchika Kusano and Motoko Nose and Tetsunori Saikawa and Kazufumi Hiramatsu and Shigeru Kohno and Yoichi Hirakata and Nobuhisa Yamane and Isamu Nakasone and Yoshinori Yamano",
year = "2008",
month = "9",
language = "English",
volume = "56",
pages = "562--579",
journal = "Japanese Journal of Chemotherapy",
issn = "1340-7007",
publisher = "Japan Society of Chemotherapy",
number = "5",

}

TY - JOUR

T1 - Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2004

AU - Yoshida, Isamu

AU - Fujimura, Takaji

AU - Itoh, Yoshihisa

AU - Tachibana, Mineji

AU - Kaku, Mitsuo

AU - Kanemitsu, Keiji

AU - Takahashi, Choichiro

AU - Shiotani, Joji

AU - Ono, Yuka

AU - Baba, Hisashi

AU - Matsuo, Shuji

AU - Asari, Seishi

AU - Matsuoka, Kimiko

AU - Kusano, Nobuchika

AU - Nose, Motoko

AU - Saikawa, Tetsunori

AU - Hiramatsu, Kazufumi

AU - Kohno, Shigeru

AU - Hirakata, Yoichi

AU - Yamane, Nobuhisa

AU - Nakasone, Isamu

AU - Yamano, Yoshinori

PY - 2008/9

Y1 - 2008/9

N2 - We determined MICs of antibacterial agents against 1,248 clinical strains of aerobic Gram-negative bacteria (19 genus or species) isolated at 16 Japanese facilities in 2004. MICs were determined using mostly broth microdilution method and antibacterial activity was assessed. Antibacterial susceptibility of Enterobacteriaceae to most β-lactams was comparable to that described in our previous report on isolates in 2002. Strains producing extended-spectrum β-lactamases(ESBL) accounted for 2.5% of Escherichia coli, 0% of Klebsiella spp., and 9.2% of Proteus spp. Notably, 16.7% of Proteus mirabilis was found to produce ESBL. Most antibacterial agents showed good activity against Moraxella catarrhalis. Among Haemophilus influenzae, 9.3% produced β-lactamase and 57.7% were β-lactamase-negative ampicillin-resistant strains when classified by penicillin-binding protein 3 mutation. Although few antibacterial agents against Pseudomonas aeruginosa have potent activity, only three agents-tobramycin, doripenem, and amikacin-showed an MIC90 of ≤8 μg/mL. Of all P. aeruginosa strains, 8.9% were resistant to seven or more agents of ten antipseudomonal agents, a decrease compared to results reported in 2002. Against other glucose-non-fermentative Gram-negative bacteria, the activity of most antibacterial agents was similar to that in 2002.

AB - We determined MICs of antibacterial agents against 1,248 clinical strains of aerobic Gram-negative bacteria (19 genus or species) isolated at 16 Japanese facilities in 2004. MICs were determined using mostly broth microdilution method and antibacterial activity was assessed. Antibacterial susceptibility of Enterobacteriaceae to most β-lactams was comparable to that described in our previous report on isolates in 2002. Strains producing extended-spectrum β-lactamases(ESBL) accounted for 2.5% of Escherichia coli, 0% of Klebsiella spp., and 9.2% of Proteus spp. Notably, 16.7% of Proteus mirabilis was found to produce ESBL. Most antibacterial agents showed good activity against Moraxella catarrhalis. Among Haemophilus influenzae, 9.3% produced β-lactamase and 57.7% were β-lactamase-negative ampicillin-resistant strains when classified by penicillin-binding protein 3 mutation. Although few antibacterial agents against Pseudomonas aeruginosa have potent activity, only three agents-tobramycin, doripenem, and amikacin-showed an MIC90 of ≤8 μg/mL. Of all P. aeruginosa strains, 8.9% were resistant to seven or more agents of ten antipseudomonal agents, a decrease compared to results reported in 2002. Against other glucose-non-fermentative Gram-negative bacteria, the activity of most antibacterial agents was similar to that in 2002.

KW - Clinical isolate

KW - Drug susceptibility

KW - Gram-negative bacteria

KW - Multidrug-resistant pseudomonas aeruginosa

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=67650712927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650712927&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:67650712927

VL - 56

SP - 562

EP - 579

JO - Japanese Journal of Chemotherapy

JF - Japanese Journal of Chemotherapy

SN - 1340-7007

IS - 5

ER -